Search - tctmd.com

Displaying 141 - 160 of 174

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Presentation ESC 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

Presentation CIT 2019

PCI for Patients with Very Low EF

Presenter: Ron Waksman

March 28, 2019

Presentation TCT Abstracts Posters 2018

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Presenter: Abdalla Hassan

September 25, 2018

Presentation TCT 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Presenter: Mackram F. Eleid

October 30, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

Presentation TCT 2016

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Presenter: Daniel Burkhoff, Ileana L. Pina, Samuel J. Asirvatham

October 30, 2016

Presentation

Impact of Ejection Fraction and Aortic Valve Gradient on TAVR Outcomes

Presenter: Suzanne Baron

May 16, 2016

Presentation

Transcatheter Intracardiac Shunt Device for Heart Failure With Preserved Ejection Fraction

Presenter: Gerd Hasenfuss

March 29, 2016

$Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis$

Presentation JIM 2016

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Presenter: Paolo Pagnotta

February 12, 2016

Presentation TCT 2015

Heart Failure With Preserved Ejection Fraction: Drugs and Devices

Presenter: Daniel Burkhoff, Ileana L. Pina, Peter Carson

October 12, 2015

Presentation

ICD Use Among Medicare Patients With Low Ejection Fraction After Acute MI

Presenter: Sean D. Pokorney

June 24, 2015

Presentation TCT 2014

Thoughtful Insights

Presenter: Michael J. Mack

September 17, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Philippe Pibarot

September 17, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: James B. Hermiller Jr

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 17, 2014

Presentation TCT 2014

Midterm Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved Ejection Fraction

Presenter: Finn Gustafsson

September 16, 2014

Advertisement

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

PCI for Patients with Very Low EF

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

New Targets: Heart Failure With Preserved Ejection Fraction

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Impact of Ejection Fraction and Aortic Valve Gradient on TAVR Outcomes

Transcatheter Intracardiac Shunt Device for Heart Failure With Preserved Ejection Fraction

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Heart Failure With Preserved Ejection Fraction: Drugs and Devices

ICD Use Among Medicare Patients With Low Ejection Fraction After Acute MI

Thoughtful Insights

Thoughtful Insights

Thoughtful Insights

Case Presentation

Midterm Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content